This federal contract award, valued at $7,080.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The specific award is for the drug product Myrbetriq ER 50 mg Tablet, with a completion date of December 17, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive federal contracting experience and distribution capabilities make it a key vendor for supplying critical medical commodities to various government agencies and military healthcare systems.
Generated 3/17/25, 9:59 AM